Your browser doesn't support javascript.
loading
EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model.
Han, Xin-Peng; Zhang, Fang-Qi; Tan, Xiang-Shu; Liu, Liang; Ma, Wen-Xian; Ou-Yang, Hai-Feng; Wu, Chang-Gui.
Affiliation
  • Han XP; Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Zhang FQ; Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Tan XS; Department of Internal Medicine, Xi'an Jiaotong University Hospital, Xi'an Jiaotong University, Xi'an, China.
  • Liu L; Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Ma WX; Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Ou-Yang HF; Department of Respiratory Medicine, Baoan District Central Hospital, Shenzhen, China.
  • Wu CG; Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
J Cell Biochem ; 119(1): 1008-1016, 2018 01.
Article in En | MEDLINE | ID: mdl-28686347

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Erythropoietin / Disease Models, Animal / Airway Remodeling / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Cell Biochem Year: 2018 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Erythropoietin / Disease Models, Animal / Airway Remodeling / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Cell Biochem Year: 2018 Type: Article Affiliation country: China